| Name | Title | Contact Details |
|---|---|---|
Bruce Gray |
Chief Information and Digital Officer | Profile |
Ryan Zea |
Director of Emerging Technology | Profile |
Tod Wiederholt |
Director of Infrastructure Technology | Profile |
Tod Wiederholt |
Director, Infrastructure Technology | Profile |
Jill Gunnufson Buh |
Deputy Information System Security Officer | Profile |
Metamark Genetics, Inc. is a privately held biotechnology company founded in 2007 to develop novel, function-based, prognostic and diagnostic tests aimed at improving cancer care. The company's proprietary genomic and proteomic discovery platforms have yielded significant discoveries in several disease areas, including prostate, colon, and breast cancers. In early 2014, Metamark plans to commercialize ProMark™—its prostate cancer prognostic test—through its Cambridge, Massachusetts CLIA-certified laboratory. For more information, please visit the company's Website at www.metamarkgenetics.com. Metamark™ and ProMark™ are trademarks of Metamark Genetics, Inc.
Vivascience is a Carlsbad, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Fairview-University Medical Center is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Legacy Press is a Blackwood, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services, is the nations medical research agency — making important discoveries that improve health and save lives.